PATH is a global organization that works to accelerate health equity by bringing together public institutions, businesses, social enterprises, and investors to solve the world’s most pressing health challenges. With expertise in science, health, economics, technology, advocacy, and dozens of other specialties. PATH develops and scales solutions—including vaccines, drugs, devices, diagnostics, and innovative approaches to strengthening health systems worldwide.
Enteric and Diarrheal Diseases (EDD) is a vaccine development and introduction program within CVIA and is identifying the most promising vaccines and associated technologies and implementing targeted partnerships across all sectors. EDD works with government, industry, non-profit, and academic partners in development, clinical testing, and preparing for the introductions of a portfolio of vaccines. With later-stage vaccine candidates, EDD manages clinical trial sites in multiple countries and works with a range of stakeholders to ensure the highest quality trials that produce crucial information for public health decision making, both in-country and globally.
Reporting to the Global Head of the Enteric and Diarrheal Diseases (EDD) Diseases Area, the Initiative Team Leader for Rotavirus Vaccines develops and directs strategy, high-level tactics and implementation for vaccine development and introduction consistent with PATH’s mission, values, and policies and CVIA goals and objectives. In addition, the Initiative Team Leader for Rotavirus Vaccines has senior-most level leadership and management responsibilities for overseeing animal models and biological assays, clinical assays and immune analytics, and immunological assays that support the EDD portfolio of rotavirus vaccine development and introduction projects. The Initiative Team Leader for Rotavirus Vaccines is also an integral part of the EDD leadership team as a change leader, strategy creator, proactive partner in developing comprehensive cross-disciplinary tactics and an enabler of exceptional execution through cross-group collaboration.
The position responsibilities include:
- Develop and direct overall strategy and implementation for EDD’s rotavirus vaccine portfolio and activities, and provide leadership in a manner consistent with PATH’s mission, values and policies.
- Lead programmatic, administrative, organizational, and financial management as the single point of accountability (Principal Director or RPM) for delivery of grant and/or contract objectives concerning EDD’s rotavirus vaccines portfolio.
- Work with and manage a network of industry partners and collaborating institutions to create and execute plans, complete pre-clinical evaluations, conduct clinical studies, achieve licensure and (if warranted) WHO prequalification, and advance vaccine introduction of EDD’s rotavirus vaccines portfolio.
- Maintain and strengthen relationships with primary stakeholders, including collaborating and partner agencies, public sector organizations, donors, and biotechnology and pharmaceutical companies, with an emphasis on manufacturing partners in emerging-market economies, such as China, India, Indonesia and South Africa.
- Lead a resource-mobilization strategy for robust funding of ongoing and new EDD projects concerning rotavirus vaccines; ensure adequate funding to fulfill program/project goals; this includes the submission of grant applications to traditional and new funding sources.
- Provide strategic oversight and technical guidance for designing, planning, monitoring, evaluating and reporting, including publishing results related to animal models, biological and immunological assays, clinical assays and immune analytics; all in support of the EDD rotavirus vaccines portfolio.
- In partnership with the Global Heads of Regulatory, CMC, Quality, and Clinical, provide strategic oversight and technical guidance for the design, planning, review and approval of regulatory and clinical submission documents that support the EDD rotavirus vaccines portfolio, and as well ensure that all clinical studies comply with international standards of research ethics and medical science.
- Develop and implement strategic tactical documents including stage appropriate Value Propositions, Target Product Profiles, Results Frameworks, and Integrated Product Development/Lifecycle Management Plans.
- Represent PATH to the international community, serve as needed on global technical advisory groups, participate in relevant vaccine development and implementation conferences, and ensure quality and rigor of published articles prepared by teams supporting EDD’s rotavirus vaccines portfolio.
- Serve as a member of the EDD leadership team partnering with other leadership and team members to support the goals and objectives of EDD
- Oversee annual work plans and compliance with all donor requirements for EDD’s rotavirus vaccines portfolio.
- Lead a staff of Disease Area scientists and functional area staff supporting EDD’s rotavirus vaccines portfolio.
- Ensure technical due diligence of potential vendors/partners for all work in support of the EDD rotavirus vaccines portfolio.
- Ensure cost-effective and high-quality management of EDD rotavirus vaccines projects.
- Model clear, open, and collaborative communication approaches within and outside of PATH.
- Provide coaching, professional development, counseling, and performance feedback to all employees supporting EDD’s rotavirus vaccines portfolio.
- Other tasks and activities as required by the Global Head of EDD